Fengbo Zhao

1.1k total citations
29 papers, 637 citations indexed

About

Fengbo Zhao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fengbo Zhao has authored 29 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Fengbo Zhao's work include Ubiquitin and proteasome pathways (4 papers), Magnesium in Health and Disease (4 papers) and MicroRNA in disease regulation (3 papers). Fengbo Zhao is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Magnesium in Health and Disease (4 papers) and MicroRNA in disease regulation (3 papers). Fengbo Zhao collaborates with scholars based in China, United Kingdom and United States. Fengbo Zhao's co-authors include Xiufang Lv, Baoying Hu, Aifen Liu, Wenxin Qin, Qiujin Shen, Jing Shi, Yin Zhao, Jia Fan, Jing Wang and Zhouhong Ge and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Fengbo Zhao

27 papers receiving 632 citations

Peers

Fengbo Zhao
Úrsula Muñoz Spain
Lauren DeVine United States
Wenjing Xing China
Zhiyu Yang Australia
H. Misawa Japan
Wanfu Wu United States
Asako Itaya‐Hironaka Japan
Yajing Chen China
Úrsula Muñoz Spain
Fengbo Zhao
Citations per year, relative to Fengbo Zhao Fengbo Zhao (= 1×) peers Úrsula Muñoz

Countries citing papers authored by Fengbo Zhao

Since Specialization
Citations

This map shows the geographic impact of Fengbo Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengbo Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengbo Zhao more than expected).

Fields of papers citing papers by Fengbo Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengbo Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengbo Zhao. The network helps show where Fengbo Zhao may publish in the future.

Co-authorship network of co-authors of Fengbo Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengbo Zhao. A scholar is included among the top collaborators of Fengbo Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengbo Zhao. Fengbo Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Zhihui, Qizhang Li, Fengbo Zhao, et al.. (2025). Tylophora yunnanensis extract inhibits cholesterol biosynthesis to suppress triple negative breast cancer. Journal of Ethnopharmacology. 348. 119877–119877.
2.
Zhao, Fengbo, et al.. (2025). How digital leadership impacts community resilience: a moderated mediation model. Frontiers in Public Health. 13. 1524985–1524985.
3.
Zhao, Fengbo, Weili Yu, Yi Xia, et al.. (2024). Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma. European Journal of Pharmacology. 974. 176601–176601. 7 indexed citations
4.
Sun, Rong, Fengbo Zhao, Yuanyuan Wu, et al.. (2023). Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion. Oncogenesis. 12(1). 56–56. 6 indexed citations
5.
Ni, Wenkai, Panpan Ma, Fengbo Zhao, et al.. (2021). The endoribonuclease N4BP1 prevents psoriasis by controlling both keratinocytes proliferation and neutrophil infiltration. Cell Death and Disease. 12(5). 488–488. 15 indexed citations
6.
Zhao, Fengbo, et al.. (2017). Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 495(1). 1136–1143. 27 indexed citations
7.
Zhang, Xiubing, Hua Lu, Fengbo Zhao, et al.. (2016). Overexpression of PCBP2 contributes to poor prognosis and enhanced cell growth in human hepatocellular carcinoma. Oncology Reports. 36(6). 3456–3464. 36 indexed citations
8.
Liu, Aifen, Fengbo Zhao, Jing Wang, et al.. (2016). Regulation of TRPM7 Function by IL-6 through the JAK2-STAT3 Signaling Pathway. PLoS ONE. 11(3). e0152120–e0152120. 13 indexed citations
9.
Lu, Hua, Baoying Hu, Jinxia Liu, et al.. (2016). Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma. Pathology - Research and Practice. 213(6). 688–697. 11 indexed citations
10.
Liu, Aifen, Fengbo Zhao, Jing Wang, et al.. (2016). Effects of vagus nerve stimulation on cognitive functioning in rats with cerebral ischemia reperfusion. Journal of Translational Medicine. 14(1). 101–101. 55 indexed citations
11.
Lv, Xiufang, Fengbo Zhao, Xisong Huo, et al.. (2016). Neuropeptide Y1 receptor inhibits cell growth through inactivating mitogen-activated protein kinase signal pathway in human hepatocellular carcinoma. Medical Oncology. 33(7). 70–70. 20 indexed citations
12.
Yang, Juan, Cun Wang, Fengbo Zhao, et al.. (2016). Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect. Carcinogenesis. 38(2). bgw109–bgw109. 47 indexed citations
13.
Hu, Baoying, Dawei Jiang, Yuyan Chen, et al.. (2015). High CHMP4B expression is associated with accelerated cell proliferation and resistance to doxorubicin in hepatocellular carcinoma. Tumor Biology. 36(4). 2569–2581. 19 indexed citations
14.
Deng, Xuan, Xin‐Rong Yang, Haojie Jin, et al.. (2015). Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma. Oncogene. 34(49). 6007–6017. 38 indexed citations
15.
Ge, Tianxiang, Qiujin Shen, Ning Wang, et al.. (2015). Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma. Medical Oncology. 32(3). 59–59. 50 indexed citations
16.
17.
Hu, Baoying, Runzhou Ni, Dawei Jiang, et al.. (2014). The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Molecular and Cellular Biochemistry. 396(1-2). 175–185. 16 indexed citations
18.
Zhang, Jing, Fengbo Zhao, Yin Zhao, et al.. (2011). Hypoxia Induces an Increase in Intracellular Magnesium via Transient Receptor Potential Melastatin 7 (TRPM7) Channels in Rat Hippocampal Neurons in Vitro. Journal of Biological Chemistry. 286(23). 20194–20207. 36 indexed citations
19.
Tan, Yan, Bin Zhao, Qingchun Zeng, et al.. (2009). Characteristics of ATP-activated current in nodose ganglion neurons of rats. Neuroscience Letters. 459(1). 25–29. 10 indexed citations
20.
Li, Zhi‐Wang, Jian Zhang, Changhan Ouyang, et al.. (2009). Potentiation by WIN 55,212‐2 of GABA‐activated currents in rat trigeminal ganglion neurones. British Journal of Pharmacology. 158(8). 1904–1910. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Úrsula Muñoz Breakdown of academic impact, for papers by Lauren DeVine Breakdown of academic impact, for papers by Wenjing Xing Breakdown of academic impact, for papers by Zhiyu Yang Breakdown of academic impact, for papers by H. Misawa Breakdown of academic impact, for papers by Wanfu Wu Breakdown of academic impact, for papers by Asako Itaya‐Hironaka Breakdown of academic impact, for papers by Yajing Chen
Rankless by CCL
2026